Company Profile of HUNAN FURUI BIOPHARMA TECHNOLOGY CO., LTD.

Hunan Furui Biopharma Technology Co., Ltd. was founded in February 2017, located in Xiangtan city, Hunan province. It covers an area of 61300 ㎡ , with a total investment of RMB 200 million. Our main business is R&D, production and sales of special APIs and pharmaceutical intermediates. We also provide customized processing and R&D services for customers. We have 3 synthesis workshops, 1 refining drying and packing workshop, as well as supporting warehouses, underground tank field, waste water treatment stations, exhaust gas absorption devices, boilers and other ancillary facilities, with a total construction area of 15,181.63㎡. The total area of production workshops is about 11,000 ㎡. The R&D and pilot team of the company is composed of 2 doctors, 4 masters and 45 professional technicians with years of R&D experience. The technical team is strong, and can be engaged in the process route development and customized processing of intermediates and raw materials from grams to kilograms under the reaction conditions from -100℃ to 300℃. We have 200 production workers including 140 highly educated workers that can produce almost all kinds of intermediates and APIs from 100 kilograms to tons. We obtained the Drug Manufacturing certificate in 2022, and passed GMP certification in 2023. The main products are used in the fields of diabetes, liver disease, cardiovascular and cerebrovascular, etc. The products have the characteristics of great difficulty in R&D, high technical barriers and unique production process. R&D strength is the core competitiveness of the company. We maintain a high investment in R&D every year. In addition we set up a R&D center in Shanghai. We maintain good R&D cooperation with many universities and research institutes.